Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in MalaysiaRevathi Rajagopal, Wan Ariffin Abdullah, Sayyidatul Abd-Ghafar et al.|Journal of Global Oncology|2016Cited by 28
Delayed Intensification Including Venetoclax and Bortezomib Prolongs Survival in Very High Risk Acute Lymphoblastic LeukaemiaJasmeet Sidhu, Shekhar Krishnan, Debjani Ghosh et al.|Blood|2023Cited by 1
Phenotypic Drug Response Profiling Identifies Asparaginase-Based Synergistic Combinations for Very High Risk Acute Lymphoblastic LeukaemiaJasmeet Sidhu, Jean‐Pierre Bourquin, Fabio D. Steffen et al.|Blood|2023Cited by 1
Functional precision approach in patients with very high risk acute lymphoblastic leukaemia in India: a single-centre cohort studyJasmeet Sidhu, Vaskar Saha, Arijit Chakraborty et al.|Unknown|2026Cited by 0